New drugs for unresectable or recurrent gastric cancer--paclitaxel and docetaxel
Yoshida, M.; Ohtsu, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 59(Suppl 4): 404-408
2001
ISSN/ISBN: 0047-1852 PMID: 11424415 Document Number: 532461
Document emailed within 1 workday
Related Documents
Ojima, E.; Nishimura, G.; Nishijima, K.; Futagami, F.; Nakamura, T.; Hosokawa, A. 2012: A case of unresectable HER2-positive advanced gastric cancer successfully treated by combination therapy with trastuzumab and paclitaxel Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 2339-2341Nimura, H.; Mitsumori, N.; Takahashi, N.; Kashimura, H.; Takayama, S.; Kashiwagi, H.; Yanaga, K. 2006: S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 1): 106-109
Oikawa, Y.; Takahashi, M.; Takahashi, S.; Matsumoto, S.; Kenno, S.; Noguchi, K.; Kakisaka, T.; Tahara, M.; Yamagami, H.; Ishizu, H. 2016: Analysis of Oxaliplatin Combination Therapy for Unresectable or Recurrent Gastric Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1579-1581
Takizawa, M.; Hirano, M.; Murakami, N.; Uno, Y.; Kikuchi, T.; Nozawa, H.; Hara, T.; Asaumi, Y.; Kikkawa, H. 2002: A case of recurrent gastric cancer that responded dramatically to docetaxel and 5'-DFUR combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1647-1650
Makari, Y.; Fujiwara, Y.; Yasuda, T.; Takiguchi, S.; Kimura, Y.; Yano, M.; Monden, M. 2004: Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(4): 609-611
Tsubono, M.; Kaneko, I.; Kii, E.; Tanaka, T.; Murata, T.; Kamimura, K.; Kida, A. 2004: Weekly administration of paclitaxel might be beneficial against TS-1-resistant recurrent gastric cancer--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(8): 1237-1241
Hikino, H.; Yamada, T.; Hata, T.; Nakamura, K.; Sugimoto, S.; Kanazawa, A.; Tokuka, A.; Ozaki, N. 2004: Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(5): 759-761
Nagata, N.; Kimura, M.; Hirabayashi, N.; Tuburaya, A.; Murata, T.; Kondo, K.; Fukuda, Y.; Kobayashi, M.; Miyashita, Y.; Nakao, A.; Sakamoto, J. 2008: Phase Ii study of weekly paclitaxel and cisplatin combination therapy for advanced or recurrent gastric cancer Hepato-Gastroenterology 55(86-87): 1846-1850
Royer, I.; Monsarrat, B.; Sonnier, M.; Wright, M.; Cresteil, T. 1996: Metabolism of docetaxel by human cytochromes P450: interactions with paclitaxel and other antineoplastic drugs Cancer Research 56(1): 58-65
Kimura, Y.; Machida, H.; Fujitani, K.; Yamamoto, M.; Tominaga, K.; Yano, H.; Shimokawa, T.; Takiuchi, H.; Tsujinaka, T.; Furukawa, H. 2010: Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(1): 151-155
Yagi, Y.; Ichikawa, K.; Takahashi, K.; Okuda, N. 2007: A case of recurrent gastric cancer with peritoneal dissemination responding to doxifluridine/paclitaxel combination chemotherapy as third-line treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(2): 261-263
Morifuji, M.; Murakami, Y.; Yokoyama, Y.; Sasaki, M.; Hayashidani, Y.; Toge, K.; Sueda, T. 2004: A case of recurrent gastric cancer with malignant ascites responding dramatically to chemotherapy with paclitaxel infused systemically and intraperitoneally Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(12): 2027-2030
Mandic, A.; Vujkov, T.; Malbasa, Z. 2003: Paclitaxel or docetaxel combined with platinum in advanced ovarian cancer? Journal of BUON: Official Journal of the Balkan Union of Oncology 8(1): 19-22
Oura, S.; Tanino, H.; Yoshimasu, T.; Sakurai, T.; Nakamura, T.; Kokawa, Y.; Matsuyama, K.; Naito, Y. 2001: A case of docetaxel-resistant breast cancer responsive to paclitaxel therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(4): 511-514
Su, W.; Zhang, S.; Li, C.; Hao, X.; Zhang, J. 2015: Efficacy and safety analysis of paclitaxel liposome and docetaxel for the neoadjuvant chemotherapy of breast cancer Zhonghua Zhong Liu Za Zhi 37(5): 379-382
Nakano, H.; Namatame, K.; Nemoto, H.; Motohashi, H.; Nishiyama, K.; Kumada, K. 1999: A multi-institutional prospective study of lentinan in advanced gastric cancer patients with unresectable and recurrent diseases: effect on prolongation of survival and improvement of quality of life. Kanagawa Lentinan Research Group Hepato-Gastroenterology 46(28): 2662-2668
Cocconi, G.; Salvagni, S.; Passalacqua, R.; Ferrozzi, F.; Camisa, R. 2004: Design and development of new combinations of the CMF agents with taxanes (paclitaxel or docetaxel) in advanced breast cancer: a feasibility study Tumori 90(3): 280-284
Nakamoto, S.; Nishiyama, R.; Kaneda, T.; Yokota, M.; Kawamata, H.; Tajima, H.; Kaizu, T.; Kumamoto, Y.; Yamauchi, H.; Okuwaki, K.; Iwai, T.; Imaizumi, H.; Suzuki, E.; Hara, A.; Ichinoe, M.; Kida, M.; Watanabe, M. 2017: Conversion Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer Following Gemcitabine plus Nab-Paclitaxel - A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 44(2): 173-176
Aoki, T.; Hyuga, S.; Kato, A.; Chono, T.; Watanabe, R.; Komori, T.; Matsumoto, T.; Takachi, K.; Nishioka, K.; Uemura, Y.; Kobayashi, K. 2012: Utility of the WallFlexTM duodenal stent for unresectable advanced gastric cancer related to gastric outlet obstruction Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(12): 1855-1856
Urabe, S.; Fujiwara, H.; Egawa, M.; Fujitou, N.; Sakashita, T.; Date, K.; Mizunoe, T.; Ueda, K.; Urabe, T. 2004: Recurrent ovarian cancer with cancer peritonitis treated with weekly paclitaxel infusion--a clinicopharmacological study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(3): 449-451